Stevens-Johnson syndrome and worsening of a systemic lupus induced by terbinafine;Syndrome de Stevens-Johnson et aggravation d'un lupus systémique induits par la terbinafine

Annales de Dermatologie et de Venereologie

Volumn 133, Issue 5 I, 2006, Pages 463-466

  Terrab, Z ^a,b   El Ouazzani, T ^a   Zouhair, K ^a   El Kabli, H ^a   Lakhdar, H ^a  

^a IBN ROCHD UNIVERSITY HOSPITAL   (Morocco)

^b NONE   (Morocco)

Author keywords

[No Author keywords available]

Indexed keywords

CHLOROQUINE; CORTICOSTEROID; CYCLOPHOSPHAMIDE; TERBINAFINE;

ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; DIAGNOSTIC TEST; DISEASE EXACERBATION; FEMALE; FOLLOW UP; HEMATURIA; HUMAN; KIDNEY BIOPSY; LABORATORY TEST; LUPUS ERYTHEMATOSUS NEPHRITIS; MUCOSA; NEEDLE BIOPSY; ONYCHOMYCOSIS; PROTEINURIA; STEVENS JOHNSON SYNDROME; SYSTEMIC LUPUS ERYTHEMATOSUS; TRICHOPHYTON RUBRUM;

EID: 33747646293     PISSN: 01519638     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0151-9638(06)70941-3     Document Type: Article

References (15)

1. Bonsmann G, Schiller M, Luger TA, Stander S. Terbinafine-induced subacute cutaneous lupus erythematosus. J Am Acad Dermatol 2001;44:925-31.
2. Gupta AK, Sibbald RG, Knowles SR, Lynde CW, Shear NH. Terbinafine therapy may be associated with the development of psoriasis de novo or its exacerbation: four case reports and a review of drug induced psoriasis. J Am Acad Dermatol 1997;36:858-62.
3. Wach F, Stolz W, Rüdiger R. Severe erythema annulare centrifugum-like psoriatic eruption induced by terbinafine. Arch Dermatol 1995;131:960-1.
4. Todd P, Halpern S, Munre DD. Oral terbinafine and erythema multiforme. Clin Exp Dermatol 1995;20:247-8.
5. McGregor JM, Rustin MH. Terbinafine and erythema multiforme. Br J Dermatol 1994;131:587-8.
6. Rzany B, Mockenhopt M, Gehring W. Stevens Johnson syndrome after terbinafine therapy. J Am Acad Dermatol 1994;30:509.
7. Carstens J, Wendelboe P, Sogaard H. Toxic epidermal necrolysis and erythema multiforme following therapy with terbinafine. Acta Derm Venereol 1994;74:391-2.
8. White SI, Bowen-Jones D. Toxic epidermal necrolysis induced by terbinafine in a patient on long-term anti-epileptics. Br J Dermatol 1996;134:178-92.
9. Murphy M, Barnes L. Terbinafine induced lupus erythematosus. Br J Dermatol 1998;138:708-9.
10. Brooke R, Coulson IH, AL-Dawoud A. Terbinafine induced subacute cutaneous lupus erythematosus. Br J Dermatol 1998;139:1132-3.
11. Callen JP. Drug-induced cutaneous lupus erythematosus, a distinct syndrome that is frequently unrecognized. J Am Acad Dermatol 2001;45:315-6.
12. Callen JP, Hughes AP, Kulp-Shorten C. Subacute cutaneous lupus erythematosus induced or exacerbated by terbinafine. A report of 5 cases. Arch Dermatol 2001;137:1196-8.
13. Holmes S, Kemmett D. Exacerbation of systemic lupus erythematosus induced by terbinafine. Br J Dermatol 1998;139:1133.
14. Bégaud B, Evreux JC, Jouglard J, Lagier G. Imputabilité des effets inattendus ou toxiques des médicaments. Actualisation de la méthode utilisée en France. Therapie 1985;40:111-8.
15. Goeteyn V, Naeyaert JM, Lambert J, Mombalia L, Vermander F. Is systemic autoimmune diseases a risk factor for terbinafine-induced erythema multiforme ? Br J Dermatol 2000;142:578.